Transforming growth factor β can mediate apoptosis via the expression of TRAIL in human hepatoma cells

被引:28
作者
Herzer, K
Ganten, TM
Schulze-Bergkamen, H
Grosse-Wilde, A
Koschny, R
Krammer, PH
Walczak, H
机构
[1] Deutsch Krebsforschungszentrum, Div Apoptosis Regulat D040, D-69120 Heidelberg, Germany
[2] Deutsch Krebsforschungszentrum, Div Immunogenet, D-69120 Heidelberg, Germany
关键词
D O I
10.1002/hep.20757
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Transforming growth factor beta (TGF-beta) has been shown to induce apoptotic cell death in normal and transformed hepatocytes. However, the exact mechanism through which TGF-beta induces cell death is still unknown. We examined a potential role of various death receptor/ ligand systems in TGF-beta-induced apoptosis and identified the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) as a mediator of TGF-beta-induced apoptosis in hepatoma cells. TGF-beta-induced apoptosis is significantly impaired upon blockage of TRAIL. We show that TRAIL is upregulated in hepatoma cells upon treatment with TGF-beta, whereas TRAIL receptor levels remain unchanged. In conclusion, our results provide evidence that the TRAIL system is critically involved in TGF-beta-induced cell death in liver pathology.
引用
收藏
页码:183 / 192
页数:10
相关论文
共 51 条
  • [1] TGF-β signaling in cancer -: a double-edged sword
    Akhurst, RJ
    Derynck, R
    [J]. TRENDS IN CELL BIOLOGY, 2001, 11 (11) : S44 - S51
  • [2] Safety and antitumor activity of recombinant soluble Apo2 ligand
    Ashkenazi, A
    Pai, RC
    Fong, S
    Leung, S
    Lawrence, DA
    Masters, SA
    Blackie, C
    Chang, L
    McMurtrey, AE
    Hebert, A
    DeForge, L
    Koumenis, IL
    Lewis, D
    Harris, L
    Bussiere, J
    Koeppen, H
    Shahrokh, Z
    Schwall, RH
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (02) : 155 - 162
  • [3] Mechanisms of disease:: Role of transforming growth factor β in human disease.
    Blobe, GC
    Schiemann, WP
    Lodish, HF
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (18) : 1350 - 1358
  • [4] Regulation of tumour necrosis factor α mRNA stability by the mitogen-activated protein kinase p38 signalling cascade
    Brook, M
    Sully, G
    Clark, AR
    Saklatvala, J
    [J]. FEBS LETTERS, 2000, 483 (01) : 57 - 61
  • [5] GROWTH MODULATORY EFFECTS OF A LIVER-DERIVED GROWTH INHIBITOR, TRANSFORMING GROWTH FACTOR-BETA-1, AND RECOMBINANT TUMOR NECROSIS FACTOR-ALPHA, IN NORMAL AND NEOPLASTIC-CELLS
    CHAPEKAR, MS
    HUGGETT, AC
    THORGEIRSSON, SS
    [J]. EXPERIMENTAL CELL RESEARCH, 1989, 185 (01) : 247 - 257
  • [6] Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice
    Cretney, E
    Takeda, K
    Yagita, H
    Glaccum, M
    Peschon, JJ
    Smyth, MJ
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 168 (03) : 1356 - 1361
  • [7] The novel receptor TRAIL-R4 induces NF-κB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain
    Degli-Esposti, MA
    Dougall, WC
    Smolak, PJ
    Waugh, JY
    Smith, CA
    Goodwin, RG
    [J]. IMMUNITY, 1997, 7 (06) : 813 - 820
  • [8] Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family
    DegliEsposti, MA
    Smolak, PJ
    Walczak, H
    Waugh, J
    Huang, CP
    DuBose, RF
    Goodwin, RG
    Smith, CA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (07) : 1165 - 1170
  • [9] TGF-β signaling in tumor suppression and cancer progression
    Derynck, R
    Akhurst, RJ
    Balmain, A
    [J]. NATURE GENETICS, 2001, 29 (02) : 117 - 129
  • [10] AUTOCRINE T-CELL SUICIDE MEDIATED BY APO-1/(FAS/CD95)
    DHEIN, J
    WALCZAK, H
    BAUMLER, C
    DEBATIN, KM
    KRAMMER, PH
    [J]. NATURE, 1995, 373 (6513) : 438 - 441